Neurosurgery medical robot Remebot for the treatment of 17 patients with hypertensive intracerebral hemorrhage

Objective To verify the minimally invasive surgical approach and therapeutic effects of using the medical neurosurgery robot Remebot to treat hypertensive intracerebral hemorrhage (HICH). Methods Clinical data for 17 HICH patients were analyzed retrospectively. Hematoma evacuation and tube drainage...

Full description

Saved in:
Bibliographic Details
Published in:The international journal of medical robotics + computer assisted surgery 2019-10, Vol.15 (5), p.e2024-n/a
Main Authors: Wang, Tao, Zhao, Quan‐Jun, Gu, Jian‐Wen, Shi, Tie‐Jun, Yuan, Xujun, Wang, Jia, Cui, Shao‐Jie
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
drainage
Evacuation
Female
frameless stereotaxy
Health services
Hemorrhage
Humans
Hypertension
hypertensive
intracranial hemorrhage
Intracranial Hemorrhage, Hypertensive - diagnostic imaging
Intracranial Hemorrhage, Hypertensive - surgery
Male
Middle Aged
Neurosurgery
Neurosurgical Procedures - adverse effects
Neurosurgical Procedures - methods
Retrospective Studies
Robotic Surgical Procedures - adverse effects
Robotic Surgical Procedures - methods
robotics
Robots
Stereotaxic Techniques
Tomography, X-Ray Computed
Urokinase
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To verify the minimally invasive surgical approach and therapeutic effects of using the medical neurosurgery robot Remebot to treat hypertensive intracerebral hemorrhage (HICH). Methods Clinical data for 17 HICH patients were analyzed retrospectively. Hematoma evacuation and tube drainage using Remebot frameless stereotaxic techniques were performed for all patients, and urokinase was injected into the hematomas after the operations. Results Robot‐assisted stereotactic techniques can accurately guide hematoma punctures, and no deaths occurred among these patients. The average positioning error was 1.28 ± 0.49 mm. The average drainage duration was 3.4 days. The 3‐month postoperative follow‐up revealed improved neurological functions and quality of life for all patients. Conclusions The medical neurosurgery robot Remebot is minimally invasive, has high positional accuracy, and facilitates surgical planning according to the shape of the hematoma. Therefore, robot‐assisted surgery using Remebot represents a safe and effective treatment method for hematoma evacuation and tube drainage in HICH patients.
ISSN:1478-5951
1478-596X
DOI:10.1002/rcs.2024